Differential regulation of prodynophin, c-fos, and serotonin transporter mRNA following withdrawal from a chronic, escalating dose regimen of D-amphetamine

Synapse

Volumn 63, Issue 4, 2009, Pages 257-268

  Horner, Kristen A ^a,b   Noble, Erika S ^a   Lauterbach, Edward C ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Depression; Immediate early gene; Limbic system; Monoamine; Opioid; Psychostimulant

Indexed keywords

DEXAMPHETAMINE; MESSENGER RNA; MU OPIATE RECEPTOR; PRODYNOPHIN; PROTEIN C FOS; PROTEIN PRECURSOR; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG WITHDRAWAL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIMBIC CORTEX; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT;

AMPHETAMINE; ANIMALS; AUTORADIOGRAPHY; BRAIN; BRAIN MAPPING; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALINS; GENE EXPRESSION REGULATION; MALE; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 63049130990     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20606     Document Type: Article

References (67)

1. Acri JB, Thompson AC, Shippenberg TS. 2001. Modulation of pre- and post-synaptic dopamine D2 receptor function by the selective κ opioid receptor agonist U69593. Synapse 39:343-350.
2. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. 2006. Cognitive deficits predict low treatment retention in cocaine-dependent patients. Drug Alcohol Depend 81:313-322.
3. 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25:892-903.
4. Barr AM, Markou A. 2005. Psychostimulant withdrawal as an inducing condition in animal models of depression. Neurosci Biobehav Rev 29:675-706.
5. Barr AM, Phillips AG. 1999. Withdrawal following repeated exposure to D-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement. Psychopharmacology 141:99-106.
6. Barr AM, Phillips AG. 2002. Increased successive negative contrast in rats withdrawn from an escalating-dose schedule of D-amphetamine. Pharmacol Biochem Behav 71:293-299.
7. Barr AM, Fiorina DF, Phillips AG. 1999. Effects of withdrawal from an escalating dose schedule of D-amphetamine on sexual behavior of the male rat. Pharmacol Biochem Behav 64:597-604.
8. Barr AM, Markou A, Phillips AG. 2002. A "crash" course on psychostimulant withdrawal as a model of depression. Trends Pharmacol Sci 23:475-482.
9. Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM. 1989. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46:243-250.
10. Berger B, Rothmaier AK, Wedekind F, Zentner J, Feuerstein TJ, Jackisch R. 2006. Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex. Br J Pharmacol 148:795-806.
11. Blakely RD, Berson HE, Fremeau RT Jr, Caron MG, Peek MM, Prince HK, Bradley CC. 1991. Cloning and expression of a functional serotonin transporter from rat brain. Nature 354:66-70.
12. Bolam JP, Izzo PN, Graybiel AM. 1988. Cellular substrate of the histochemically defined striosome and matrix system of the caudate nucleus: A combined golgi and immunocytochemical study in cat and ferret. Neuroscience 24:853-875.
13. Canales JJ. 2005. Stimulant-induced adaptations in neostriatal matrix and striosome systems: Transiting from instrumental responding to habitual behavior in drug addiction. Neurobiol Learn Mem 83:93-103.
14. Canales JJ, Graybiel AM. 2000. A measure of striatal function predicts motor stereotypy. Nat Neurosci 3:377-383.
15. Cardinal RN, Parkinson JA, Hall J, Everitt BJ. 2002. Emotion and motivation: The role of the amygdala, ventral striatum and prefrontal cortex. Neurosci Biobehav Rev 26:321-352.
16. Carlezon WA Jr, Thorne J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ. 1998. Regulation of cocaine reward by CREB. Science 282:2272-2275.
17. Civelli O, Douglass J, Goldstein A, Herbert E. 1985. Sequence and expression of the rat dynorphin gene. Proc Natl Acad Sci USA 82:4291-4295.
18. Clow DW, Hammer RP Jr. 1991. Cocaine abstinence following chronic treatment alters cerebral metabolism in dopaminergic reward regions- bromocriptine enhances recovery. Neuropsychopharmacology 4:71-75.
19. Coffey SF, Danksy BS, Carrigan MH, Brady KT. 2000. Acute and protracted cocaine abstinence in an outpatient population: A prospective study of mood, sleep and withdrawal symptoms. Drug Alcohol Depend 59:277-286.
20. Curran T, Gordon MB, Rubinko KL, Sambucetti LC. 1987. Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2:79-84.
21. Drevets WC. 2001. Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 11:240-249.
22. Ershce KD, Clark L, London M, Robbins TW, Sahakian BJ. 2006. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 31:1036-1047.
23. Fallon JH, Leslie FM. 1986. Distribution of dynorphin and enkephalin peptides in the rat brain. J Comp Neurol 249:293-336.
24. Foote RW, Maurer R. 1982. Autoradiographic localization of opiate κ-opiate receptors in the guinea pig brain. Eur J Pharmacol 85:99-103.
25. Gawin FH, Kleber HD. 1986. Abstinence symptomology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43:107-113.
26. Glickstein SB, Schmauss C. 2004. Focused stereotypies do not require enhacned activation of neurons in striosomes. J Comp Neurol 469:277-283.
27. Goodman RR, Snyder SH. 1982. Autoradiographic localization of κ opiate receptors to deep layers of the cerebral cortex may explain unique sedative and analgesic effects. Life Sci 31:1291-1294.
28. Grahn RE, Maswood S, McQueen MB, Watkins LR, Maier SF. 1999. Opioid-dependent effects of inescapable shock on escape behavior and conditioned fear responding are mediated by the dorsal raphe nucleus. Behav Brain Res 99:153-167.
29. Harbuz MS, Lightman SL. 1992. Stress and the hypothalamo-pituitary- adrenal axis: Acute, chronic and immunological activation. J Endocrinol 134:327-339.
30. Hastings RS, Parsey RV, Oquendo MA, Arango V, Mann JJ. 2004. Volumetric analysis of the prefrontal cortex, amygdala and hippocampus in major depression. Neuropsychopharmacology 29:952-959.
31. Horner KA, Keefe KA. 2006. Regulation of psychostimulant-induced preprodynorphin, c-fos and zif/268 messenger RNA expression in the rat dorsal striatum by μ opioid receptor blockade. Eur J Pharmacol 532:61-73.
32. Huang YH, Cheng CY, Hong CJ, Tsai SJ. 2004. Expression of c-Fos-like immunoreactivity in the brain of mice with learned helplessness. Neurosci Lett 363:280-283.
33. Hurd YL. 2002. Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex. Mol Psychiatry 7:75-81.
34. Johnson JG, Gerfen CR, Haber SN, van der Kooy D. 1990. Mechanisms of striatal pattern formation: Conservation of mammalian compartmentalization. Dev Brain Res 57:93-102.
35. Jolas T, Aghajanian GK. 1997. Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res 755:229-245.
36. Loubinoux I, Tombari D, Pariente J, Gerdelat-Mas A, Franceries X, Cassol E, Rascol O, Pastor J, Chollet F. 2005. Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer. Neuroimage 27:299-313.
37. Mansour A, Fox CA, Akil H, Watson SJ. 1995. Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci 18:22-29.
38. McEwen BS. 1999. Stress and hippocampal plasticity. Ann Rev Neurosci 22:105-122.
39. Melia KR, Ryabinin AE, Schroeder R, Bloom FE, Wilson MC. 1994. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J Neurosci 14:5929-5938.
40. Milak MS, Parsey RV, Keilp J, Oquendo MA, Malone KM, Mann JJ. 2005. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry 62:397-408.
41. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiol Depress 3413-25.
42. Owens MJ, Nemeroff CB. 1994. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 40:288-295.
43. Parsey RV, Hastings RS, Oquendo MA, Huang Y-Y, Simpson N, Arcement J, Huang Y, Odgen RT, Van Heertum RL, Arango V, Mann JJ. 2006. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 163:52-58.
44. Paxinos G, Watson C. 2005. The rat brain in stereotaxic coordinates. Burlington, MA: Elsevier Academic Press.
45. Persico AM, Schindler CW, Zaczek R, Brannock MT, Uhl GR. 1995. Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: Alterations during rat amphetamine withdrawal and following chronic injection stress. Synapse 19:212-227.
46. Persico AM, Schindler CW, Davis SC, Ambrosio E, Uhl GR. 1998. Medial prefronal cortical injections of c-fos antisense oligonucleotides transiently lower c-Fos protein and mimic amphetamine withdrawal behaviors. Neuroscience 82:1115-1129.
47. Phelps EA, LeDoux JE. 2005. Contributions of the amygdala to emotional processing: From animal models to human behavior. Neuron 48:175-187.
48. Ramamoorthy S, Blakely RD. 1999. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285:763-766.
49. Reidel WJ, Klaassen T, Griez E, Honig A, Menheere PPCA, van Praag HM. 2002. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: Evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology 26:358-367.
50. Saka E, Iadarola M, Fitzgerald DJ, Graybiel AM. 2002. Local circuit neurons in the striatum regulate neural and behavioral responses to dopaminergic stimulation. Proc Natl Acad Sci USA 99:9004-9009.
51. Sapolsky RM. 2000. The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death. Biol Psychiatry 48:755-765.
52. Sato M, Morita Y, Saika T, Fujita M, Ohhat K, Tohyama M. 1991. Localization and ontogeny of cells expressing preprodynorphin mRNA in the rat cerebral cortex. Brain Res 541:41-49.
53. Sbrenna S, Marti M, Morari M, Calo G, Guerrini R, Beani L, Bianchi C. 2000. Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin. Br J Pharmacol 130:425-433.
54. Sheline YI, Gado MH, Price JL. 1998. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 9:2023-2028.
55. Shirayama Y, Ishida H, Iwata M, Hazama G, Kawahara R, Duman RS. 2004. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90:1258-1268.
56. Tao R, Auerbach SB. 2002. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. J Pharmacol Exp Ther 303:549-556.
57. Thiebot MH, Martin P, Puech AJ. 1992. Animal behavioural studies in the evaluation of antidepressant drugs. Br J Pharmacol Suppl 15:44-50.
58. Trujillo KA, Day R, Akil H. 1990. Regulation of striatonigral prodynorphin peptides by dopaminergic agents. Brain Res 518:244-256.
59. Turchan J, Przewlocka B, Lason W, Przewlocki R. 1998. Effects of repeated psychostimulant administration on the prodynorphin system activity and j opioid receptor density in the rat brain. Neuroscience 85:1051-1059.
60. Turchan J, Maj M, Przewlocka B, Przewlocki R. 2002. Effect of cocaine and amphetamine on biosynthesis of proenkephalin and prodynorphin in some regions of rat limbic system. Pol J Pharmacol 54:367-372.
61. Vacca G, Ahn S, Phillips AG. 2007. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucroseevoked dopamine efflux in the rat nucleus accumbens. Neuropsychopharmacology 32:932-939.
62. van Bockstaele EJ, Biswas A, Pickel VM. 1993. Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens. Brain Res 624:188-198.
63. Vollmayr B, Keck S, Henn FA, Schloss P. 2000. Acute stress decreases serotonin transporter mRNA in the raphe pontis, but not in other nuclei of the rat. Neurosci Lett 290:109-112.
64. Wang JQ, Smith AJ, McGinty JF. 1995. A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain. Neuroscience 68:83-95.
65. Wilner P. 1984. The validity of animal models of depression. Psychopharmacology 83:1-16.
66. Wise RA. 1998. Drug-activation of brain reward pathways. Drug Alcohol Depend 51:13-22.
67. Yim CY, Mogenson GJ. 1980. Electrophysiological studies of neurons in the ventral tegmental area of Tsai. Brain Res 181:301-313.